Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
Regulated (List II)Translated
VOGALYS
7,5MG/Orodispersible Tablet/METOPIMAZINE
ManufacturerVerified lab
SALEM
Public retail price
N/ADZD
Reference price (TR): 144.20 DZD
Identification
- Active ingredient (INN)
- METOPIMAZINE
- Internal code
- 10 F 147
- Country of Origin
- Algeria
- Pharmaceutical form
- Orodispersible Tablet
- Prescription List
- Regulated (List II)
- Packaging
- b/16
Clinical View
Regulated (List II)
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Associated Conditions
Child under 6 years of age Pregnancy Hepatic impairment Renal impairment Elderly.
Mechanism of Action
Mechanism of action
Metopimazine is an antiemetic belonging to the phenothiazine class.
It is characterized by an antidopaminergic elective activity (anti-apomorphine activity) due to its very limited passage of the haematoencephalic barrier.
Adverse Effects
- Hyperprolactinaemia (Rare)
- Urticaria (Rare)
- Rash (Rare)
- Galactorrhoea (Rare)
- Gynecomastia (Rare)
- Amenorrhea (Rare)
- Frigidity (Rare)
- Oedema of Quincke (Rare)
- Hypersensitivity (Rare)
- Accommodation disorder (Very rare)
- Laryngeal disease (Rare)
- Oral dryness (Rare)
- Orthostatic hypotension (Rare)
- Constipation (Very rare)
- Trismus (Very rare)
- Spasmodic Torticolis (Very rare)
- Late dyskinesia (Very rare)
- Somnolence (Rare)
- Extrapyramidal syndrome (Very rare)
- Oculogy crisis (Very rare)
- Sedation (Rare)
- Early dyskinesia (Very rare)
- Respiratory damage (Rare)
- Urinary retention (Very rare)
- Impower (Rare).